Physician
Maryland Family Care, INC.
Maryland Family Care, INC. was paid $24.53M by Medicaid between Jan 2018 and Dec 2024, across 120 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoMARYLAND FAMILY CARE, INC.
BALTIMORE, MD 21202
BALTIMORE, MD 21202
33aNPI1598718256assigned 05/17/2006
33bProvider typeAdolescent Medicine (Family Medicine) Physician
28Total paid$24.53M
24GClaims498,588
24DCodes billed120
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,171 | $943K | |
| 2019 | 15,700 | $567K | |
| 2020 | 62,746 | $3.35M | |
| 2021 | 71,809 | $4.25M | |
| 2022 | 78,724 | $5.20M | |
| 2023 | 132,377 | $5.65M | |
| 2024incomplete | 121,061 | $4.56M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 79,968 | 72,839 | $7.36M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 98,367 | 88,382 | $6.68M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.6% | 14,714 | 14,154 | $1.63M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.4% | 15,490 | 14,372 | $1.57M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.4% | 7,570 | 7,367 | $837K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.2% | 14,713 | 4,819 | $540K |
| 99477 | 2.1% | 1,676 | 1,430 | $522K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.7% | 3,433 | 3,356 | $409K |
| 99220 | 1.5% | 4,346 | 3,886 | $379K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.4% | 6,454 | 2,562 | $341K |
| 99223 | Prolong inpt eval add15 m | 1.2% | 3,332 | 2,950 | $290K |
| 99238 | Hospital discharge day management, 30 minutes or less | 1.1% | 5,512 | 4,898 | $258K |
108 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.0% | 2,221 | $250K |
| 90670 | <1% | 9,225 | $209K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,669 | $191K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 2,009 | $180K |
| 90686 | <1% | 8,449 | $178K | |
| 90680 | <1% | 7,419 | $161K | |
| 99381 | <1% | 1,262 | $134K | |
| 93000 | <1% | 4,982 | $132K | |
| 90698 | <1% | 5,869 | $128K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 3,339 | $123K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 892 | $109K |
| 99385 | <1% | 848 | $108K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 4,055 | $108K |
| 90697 | <1% | 4,957 | $108K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,582 | $102K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,038 | $99K |
| 90633 | <1% | 4,410 | $97K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,231 | $90K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 8,914 | $88K |
| 90710 | <1% | 3,618 | $80K | |
| 90677 | <1% | 2,701 | $65K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,916 | $64K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,249 | $59K |
| 90744 | <1% | 2,676 | $58K | |
| 99226 | <1% | 1,069 | $57K | |
| 99217 | <1% | 1,900 | $56K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 631 | $55K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 456 | $52K |
| G0008 | Administration of influenza virus vaccine | <1% | 2,910 | $46K |
| D1206 | Topical application of fluoride varnish | <1% | 1,422 | $35K |
| 90682 | <1% | 1,029 | $34K | |
| 96127 | <1% | 4,946 | $29K | |
| 3074F | <1% | 45,250 | $28K | |
| 99460 | <1% | 302 | $26K | |
| 99225 | <1% | 954 | $24K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 814 | $24K |
| 99464 | <1% | 408 | $24K | |
| 92551 | <1% | 2,250 | $23K | |
| 99462 | <1% | 572 | $23K | |
| 82962 | <1% | 1,301 | $21K | |
| 90674 | <1% | 675 | $16K | |
| 90662 | <1% | 1,331 | $15K | |
| 90651 | <1% | 650 | $15K | |
| 99219 | <1% | 322 | $13K | |
| 3044F | <1% | 9,062 | $12K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 217 | $11K |
| 90696 | <1% | 452 | $10K | |
| 99221 | <1% | 100 | $10K | |
| 90661 | <1% | 496 | $9K | |
| 99386 | <1% | 59 | $9K | |
| 0072A | <1% | 225 | $9K | |
| 99205 | Prolong outpt/office vis | <1% | 47 | $9K |
| 0071A | <1% | 202 | $8K | |
| 90700 | <1% | 294 | $7K | |
| 0001A | <1% | 174 | $7K | |
| G0009 | Administration of pneumococcal vaccine | <1% | 275 | $6K |
| 99442 | <1% | 298 | $6K | |
| 0002A | <1% | 157 | $6K | |
| 99173 | <1% | 2,267 | $6K | |
| 90480 | <1% | 138 | $6K | |
| 90734 | <1% | 258 | $5K | |
| 90648 | <1% | 177 | $4K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 211 | $4K |
| 0124A | <1% | 108 | $4K | |
| 90715 | <1% | 125 | $3K | |
| 99236 | Prolong inpt eval add15 m | <1% | 15 | $3K |
| 0004A | <1% | 60 | $2K | |
| 96161 | <1% | 893 | $2K | |
| 90619 | <1% | 81 | $2K | |
| 3075F | <1% | 1,945 | $2K | |
| 99495 | <1% | 40 | $2K | |
| 99443 | <1% | 64 | $2K | |
| 99383 | <1% | 12 | $2K | |
| 91318 | <1% | 26 | $2K | |
| 0012A | <1% | 30 | $1K | |
| 91319 | <1% | 13 | $1K | |
| 0011A | <1% | 27 | $1K | |
| 90688 | <1% | 54 | $974.34 | |
| 99406 | <1% | 80 | $969.74 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 69 | $962.82 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 64 | $946.94 |
| 90381 | <1% | 16 | $895.25 | |
| 90707 | <1% | 30 | $651.84 | |
| 90716 | <1% | 30 | $651.84 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 481 | $607.50 |
| 90621 | <1% | 14 | $578.88 | |
| W7000 | <1% | 99 | $539.86 | |
| 0081A | <1% | 17 | $486.20 | |
| 80305 | <1% | 98 | $424.83 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 40 | $413.41 |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 23 | $381.38 |
| 90685 | <1% | 19 | $349.20 | |
| 90694 | <1% | 294 | $320.69 | |
| 99306 | Prolong nursin fac eval 15m | <1% | 14 | $320.49 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 12 | $178.96 |
| 90732 | <1% | 45 | $146.54 | |
| 90653 | <1% | 68 | $120.22 | |
| 36416 | <1% | 596 | $110.80 | |
| 91308 | <1% | 170 | $0.02 | |
| 91312 | <1% | 80 | $0.01 | |
| 3078F | 0% | 37,617 | $0.00 | |
| 91300 | 0% | 109 | $0.00 | |
| 3079F | 0% | 9,459 | $0.00 | |
| 91307 | 0% | 79 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 25 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 14 | $0.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 12 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROWE, WILMA (DIRECTOR)